Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial ribosome** is a cytoplasmic nucleoprotein complex responsible for translating messenger RNA into proteins. It consists of two unequal-sized **subunits**—the **small 30S** and **large 50S**—which together form the functional **70S prokaryotic ribosome**. Each contains specific types of rRNAs and numerous proteins; for example, *E. coli*'s small unit has one molecule of 16S rRNA plus about twenty-one proteins, while its large unit contains one each of 23S and 5S rRNAs plus thirty-four proteins[1][2][6]. The main biological function is catalyzing peptide bond formation during translation—a process essential for cell survival—and decoding genetic information from mRNA templates. Both structural studies using cryo-electron microscopy and biochemical analyses have revealed detailed interactions with tRNAs, mRNAs, ions, antibiotics like paromomycin, as well as post-transcriptional modifications critical for function[2][3]. Because many antibiotics selectively bind these prokaryotic-specific structures without affecting eukaryotic cytoplasmic counterparts, they are major therapeutic targets against infectious diseases caused by bacteria. However, their similarity to mitochondrial counterparts poses safety challenges regarding off-target toxicity.[3]
Drugs targeting bacterial ribosome subunits act primarily by inhibiting protein synthesis through mechanisms such as: – Blocking tRNA binding sites on the small or large rRNA components. – Disrupting peptide bond formation at the peptidyl transferase center. – Causing misreading of mRNA codons. – Preventing translocation along mRNA during translation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ribosome subunit.